- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03202420
Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic (TOPS at DOC)
Pilot Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic
The purpose of this pilot proposal are the following: 1) to determine the feasibility and acceptability of integrating the TOPS weight loss program into underserved populations through an urban safety net clinic and 2) to gather preliminary data of weight change to inform the design of a future randomized, controlled trial to determine the efficacy of the TOPS program in safety net clinics.
To achieve these goals, the investigators will pursue the following Specific Aims:
Specific Aim 1. Assess the feasibility and acceptability of integrating the TOPS program into an urban safety net clinic, with process measures (i.e., recruitment/refusal rates and retention/dropout rates) and focus groups.
Hypothesis 1. Integrating the TOPS program into an urban safety net clinic is feasible and acceptable to participants.
Specific Aim 2. Assess the percent of participants in the TOPS intervention arm with clinically significant weight change (i.e., weight loss of ≥5% of initial body weight) at 12, 26, and 52 weeks.
Hypothesis 2. 10%, 25%, and 33% of participants in the TOPS intervention arm will lose ≥5% of initial body weight at 12, 26, and 52 weeks, respectively.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27701
- Duke General Internal Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants must be patients of the DOC.
- BMI: Asian patients with a BMI of ≥23 kg/m2 and patients of other racial and ethnic backgrounds will be included if have a BMI of ≥25 kg/m2. Asian patients are allowed to participate at a BMI in the normal range because they are more likely to develop diabetes (or insulin resistance or glucose intolerance at a BMI of 23 kg/m2).
Exclusion Criteria:
- Mental illness that would cause disruptions to group meetings
- Cognitive impairment that would preclude participants from understanding the program
- Type 2 diabetics on insulin or sulfonylureas without provider approval
- untreated hyper- or hypothyroidism
- current cancer diagnosis
- history of cancer (other than skin cancer)
- gastrointestinal disorders affecting food intake
- use of medications thought to effect metabolism, body weight, energy expenditure, or appetite
- women currently pregnant or lactating, planning to become pregnant, or less than 6 months post-partum
- weight loss of > 5% in past 6 months
- major psychiatric disorder
- current moderate to severe symptoms of depression
- eating disorders
- current alcohol or substance abuse.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: TOPS
Participants will attend weekly TOPS meetings with standard weekly weigh ins
|
Take Off Pounds Sensibly (TOPS) is a national, nonprofit, peer-led, group-based, weight loss program that offers a comprehensive program on diet and physical activity with group support for weight management.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Weight
Time Frame: Baseline, 12, 24, and 52 weeks
|
Weekly weight data will be collected by the DOC Designee at baseline, 12, 24, and 52 weeks.
|
Baseline, 12, 24, and 52 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Program Attendance
Time Frame: 52 Weeks
|
Calculate the percentage of TOPS at DOC group session attendance (sessions attended/total offered).
|
52 Weeks
|
|
Retention as measured by attendance sheets
Time Frame: 12, 24 and 52 weeks
|
Calculate the retention of participants in the TOPS at DOC program at 12, 24, and 52 weeks.
|
12, 24 and 52 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nia S Mitchell, MD, MPH, Duke University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00080518
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on TOPS
-
Duke UniversityNational Institutes of Health (NIH)CompletedObesity | Breast Cancer | Weight Loss | Feasibility and Acceptability of the TOPS ProgramUnited States
-
Children's Hospital Medical Center, CincinnatiChildren's Hospital Colorado; Nationwide Children's Hospital; MetroHealth Medical... and other collaboratorsCompletedTraumatic Brain InjuryUnited States
-
Premia SpineUnknown
-
Duke UniversityNot yet recruiting
-
Premia SpineUnknownLumbar Spinal Stenosis | SpondylolisthesisUnited Kingdom
-
Hillel Yaffe Medical CenterUnknown
-
IRCCS Eugenio MedeaCompletedNeurological Diseases or ConditionsItaly
-
Impliant, Ltd.CompletedLow Back Pain | Lumbar Spinal Stenosis | Spondylolisthesis | Leg PainUnited States
-
IRCCS Eugenio MedeaIRCCS Fondazione Don Carlo Gnocchi, MilanoRecruiting
-
IRCCS Eugenio MedeaCompleted